Mark M. Schubert

Appointments and Affiliations

 
 
University of Washington
School of Dentistry
Oral Medicine
Professor, Appointed: 2000
University of Washington
School of Medicine
Otolaryngology--Head and Neck Surgery
Adjunct Associate Professor, Appointed: 1982
Fred Hutchinson Cancer Research Center
Clinical Research Division
Oral Medicine
Associate Member, Appointed: 1976
Fred Hutchinson Cancer Research Center
Clinical Research Division
Oral Medicine
Director, Appointed: 1976
Professional Headshot of Mark M. Schubert

Mailing Address

Oral Medicine G6-900
Seattle Cancer Care Alliance
825 Eastlake Ave. E
PO Box 19023
Seattle, Washington 98109
United States

Contact

Phone: (206) 288-1331
Fax: (206) 288-1332
mschuber@seattlecca.org

Degrees

M.S.D., School of Dentistry, Oral Medicine, 1981.
Certificate, School of Dentistry, Oral Medicine, 1980.
D.D.S., University of Washington, Dentistry, 1974.

Research Interests

Expertise: Dr. Schubert has over 24 years of experience in the fields of oral medicine and oral oncology (i.e., oral complications of cancer and cancer therapy) and oral infectious diseases, including the oral mnaifestations and complications associated with HIV.

Current oncology research is focused on studies related to the prevention and management of oral mucositis associated with cancer therapy. Research has focused on topical anti-infectives (antibiotics and definsins), growth factors and cytokines (KGFs and IL-11), cytoprotective agents (benzydamine, amifostine), and low level lasers therapy. Additional research interests include management strategies for other oral complications of cancer therapy including salivary gland dysfunction, oral graft-versus-host disease in allogeneic hematopooeitic cell transplant recipients, and dental growth and development problems following hematopooeitic cell transplant.

Research focus in infectious disease is currently directed at determining intra oral tissues sites infected with human herpes virus 8.

Industry

Research into strategies and agents capable of reducing or preventing oral mucositis following cancer therapy have been heavily dependant on alliances between industry and clinical oncology researchers. Given the scope of the problem when combined with the need to develop FDA-approved agents, the partnering of industry with research oriented cancer care centers has been critical. The Oral Medicine Service at the SCCA is well positioned to provide the necessary expertise and clinical research environment to move these studies ahead.

Languages

(Reading, Writing, Speaking)

English: (Fluent, Fluent, Fluent)

Memberships

International Society for Oral Oncology
Multinational Association of Supportive Care in Cancer

Honors and Awards

Omicron Kappa Upsilon, OKU Dental Honorary Fraternity, University of Washington

 

Recent Publications

2014
Devic, I, Shi M, Schubert MM, Lloid M, Izutsu KT, Pan C, Missaghi M, Morton TH, Mancl LA, Zhang J et al..  2014.  Proteomic Analysis of Saliva from Patients with Oral Chronic Graft-Versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
2012
Martin, PJ, Furlong T, Rowley SD, Pergam SA, Lloid M, Schubert MM, Horgan KJ, Storer BE.  2012.  Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(6):922-929. Abstract
2011
2010
2009
Rankin, VK, Epstein J, Hubber MA, Peterson DE, Plemons JM, Redding SS, Sanfillippo NJ, Schubert MM, Sonis ST.  2009.  Oral health in cancer therapy.. Today's FDA : official monthly journal of the Florida Dental Association. 21(8):37,39-45.
2008